ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 075,68
0,99%
Dow Jones
38 884,26
0,08%
DAX
18 430,05
1,42%
Brent Oil
83,145
-0,40%
Bitcoin
63 027,79
-0,22%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Acurx Pharmaceuticals Inc (ACXP)

  7. Acurx Pharmaceuticals Inc (ACXP) Actualités

ACXP Acurx Pharmaceuticals Inc

1,98
-0,10 (-4,81%)
Après les heures de négociation
Dernière mise à jour : 22:05:05
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Acurx Pharmaceuticals Inc ACXP NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,10 -4,81% 1,98 22:05:05
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,07 1,98 2,09 1,98 2,08
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202413:00PRNUSAcurx Pharmaceuticals Announces Presentation of Ibezapolstat..
25/4/202416:12PRNUSAcurx Pharmaceuticals Announces Presentation of..
23/4/202416:57PRNUSAcurx Pharmaceuticals, Inc. to Discuss First Quarter 2024..
19/3/202412:33IHMARKETNEWSUnilever Initiates Ice Cream Division Spin-Off and Announces..
18/3/202412:12IHMARKETNEWSAnticipation Builds on Wall Street for Federal Reserve’s..
18/3/202412:01PRNUSAcurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full..
04/3/202413:01PRNUSAcurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and..
27/2/202413:01PRNUSAcurx Announces FDA Has Granted an End of Phase 2 Meeting..
23/2/202415:30GLOBENew to The Street Announces Line-up of its Corporate..
16/2/202415:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
02/2/202415:30GLOBENew to The Street Announces its 553rd Episode TV Line Up,..
01/2/202415:33GLOBENew to The Street TV Announces Episode #552 with its Five..
29/1/202413:00PRNUSAcurx Announces Positive Extended Clinical Cure Data for..
26/1/202416:55GLOBENew to The Street Announces Episode 551, Five Corporate..
23/1/202413:01PRNUSAcurx Pharmaceuticals to Present at the Microcap Conference,..
22/1/202412:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:30GLOBENew to The Street Airs on the FOX Business Network, Episode..
17/1/202413:01PRNUSAcurx Announces Positive Comparative Microbiology and..
05/1/202415:30GLOBENew to The Street Announces its Four Corporate Interviews,..
03/1/202414:00PRNUSAcurx to present at the 42nd Annual J.P. Morgan Healthcare..
11/12/202313:01PRNUSAcurx Announces Positive Phase 2b Results Showing 100% of..
08/12/202315:46GLOBENew to The Street TV Features Five Corporate Guest..
07/12/202315:20GLOBENew to The Street TV Announces Its Episode 536 Lineup, Five..
01/12/202315:30GLOBENew to The Street Announces Five Corporate Interviews,..
24/11/202315:30GLOBENew to The Street Announces its Five Business Guest..
17/11/202315:30GLOBENew to The Street Announces Episode 530 with Six Corporate..
15/11/202323:02EDGAR2Form 8-K - Current report
15/11/202322:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/11/202313:01PRNUSAcurx Pharmaceuticals, Inc. Reports Third Quarter 2023..
02/11/202312:01PRNUSAcurx Announces Positive Top-Line Ibezapolstat Phase 2..
25/10/202313:01PRNUSAcurx Pharmaceuticals to Discuss Third Quarter 2023..
20/10/202316:43GLOBENew to The Street Announces Six Business Interviews on its..
19/10/202313:01PRNUSAcurx Announces Ibezapolstat Scientific Posters and..
02/10/202313:01PRNUSAcurx Pharmaceuticals Announces Successful Completion and..
12/9/202313:01PRNUSAcurx Announces Presentation and Update of Its pol IIIC R&D..
22/8/202313:01PRNUSAcurx Pharmaceuticals to Present at the H.C. Wainwright 25th..
14/8/202313:01PRNUSAcurx Pharmaceuticals, Inc. Reports Second Quarter 2023..
24/7/202313:01PRNUSAcurx Pharmaceuticals to Discuss Second Quarter 2023..
13/7/202322:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/7/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
07/7/202315:30GLOBENew to The Street Airs its Televised Corporate Interviews on..
30/6/202315:35GLOBENew to The Street TV / Newsmax TV Announces its Five..
20/6/202313:01PRNUSAcurx Pharmaceuticals to Present at the Emerging Growth..
15/6/202313:01PRNUSAcurx Pharmaceuticals to Participate in the Maxim Group LLC..
16/5/202314:45PRNUSAcurx Pharmaceuticals, Inc. Announces Pricing of $4.0..
12/5/202313:01PRNUSAcurx Pharmaceuticals, Inc. Reports First Quarter 2023..

Dernières Valeurs Consultées

NASDAQ
ACXP
Acurx Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés